Keiichi Mori

455 total citations
6 papers, 361 citations indexed

About

Keiichi Mori is a scholar working on Surgery, Molecular Biology and Nephrology. According to data from OpenAlex, Keiichi Mori has authored 6 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 3 papers in Molecular Biology and 2 papers in Nephrology. Recurrent topics in Keiichi Mori's work include Signaling Pathways in Disease (2 papers), Pancreatic function and diabetes (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). Keiichi Mori is often cited by papers focused on Signaling Pathways in Disease (2 papers), Pancreatic function and diabetes (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). Keiichi Mori collaborates with scholars based in Japan. Keiichi Mori's co-authors include Akifumi Kushiyama, Yusuke Nakatsu, Hideyuki Sakoda, Midori Fujishiro, Yasuka Matsunaga, Takeshi Yamamotoya, Tomoichiro Asano, Yuki Inoue, Koji Ueda and Hiraku Ono and has published in prestigious journals such as Journal of Biological Chemistry, International Journal of Molecular Sciences and American Journal of Physiology-Gastrointestinal and Liver Physiology.

In The Last Decade

Keiichi Mori

6 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keiichi Mori Japan 5 151 122 118 115 81 6 361
Yaqiu Hu China 6 135 0.9× 179 1.5× 83 0.7× 230 2.0× 40 0.5× 7 423
De Xie China 12 111 0.7× 186 1.5× 33 0.3× 169 1.5× 47 0.6× 27 452
Huimin Xian China 4 116 0.8× 270 2.2× 64 0.5× 41 0.4× 65 0.8× 7 448
Ajinath Kale India 14 51 0.3× 103 0.8× 38 0.3× 153 1.3× 33 0.4× 26 359
Ghada Abdel‐Fattah United States 9 93 0.6× 141 1.2× 83 0.7× 23 0.2× 192 2.4× 10 500
Jianan Zou China 14 50 0.3× 211 1.7× 31 0.3× 131 1.1× 187 2.3× 20 510
Wataru Ohwada Japan 11 78 0.5× 211 1.7× 89 0.8× 28 0.2× 64 0.8× 29 433

Countries citing papers authored by Keiichi Mori

Since Specialization
Citations

This map shows the geographic impact of Keiichi Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiichi Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiichi Mori more than expected).

Fields of papers citing papers by Keiichi Mori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiichi Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiichi Mori. The network helps show where Keiichi Mori may publish in the future.

Co-authorship network of co-authors of Keiichi Mori

This figure shows the co-authorship network connecting the top 25 collaborators of Keiichi Mori. A scholar is included among the top collaborators of Keiichi Mori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiichi Mori. Keiichi Mori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Takakura, Yuji, Masatoshi Kochi, Kei Kushitani, et al.. (2019). Case report of hepatic pseudocyst. International Journal of Surgery Case Reports. 62(C). 77–84. 3 indexed citations
2.
Nakatsu, Yusuke, Keiichi Mori, Yasuka Matsunaga, et al.. (2017). The prolyl isomerase Pin1 increases β-cell proliferation and enhances insulin secretion. Journal of Biological Chemistry. 292(28). 11886–11895. 21 indexed citations
3.
Nakatsu, Yusuke, Yasuka Matsunaga, Takeshi Yamamotoya, et al.. (2016). Physiological and Pathogenic Roles of Prolyl Isomerase Pin1 in Metabolic Regulations via Multiple Signal Transduction Pathway Modulations. International Journal of Molecular Sciences. 17(9). 1495–1495. 41 indexed citations
4.
Kushiyama, Akifumi, Yusuke Nakatsu, Yasuka Matsunaga, et al.. (2016). Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis. Mediators of Inflammation. 2016. 1–15. 132 indexed citations
5.
Qiang, Shirong, Yusuke Nakatsu, Midori Fujishiro, et al.. (2015). Treatment with the SGLT2 inhibitor luseogliflozin improves nonalcoholic steatohepatitis in a rodent model with diabetes mellitus. Diabetology & Metabolic Syndrome. 7(1). 104–104. 97 indexed citations
6.
Nakatsu, Yusuke, Akifumi Kushiyama, Hideyuki Sakoda, et al.. (2015). The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model. American Journal of Physiology-Gastrointestinal and Liver Physiology. 309(1). G42–G51. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yaqiu Hu Breakdown of academic impact, for papers by De Xie Breakdown of academic impact, for papers by Huimin Xian Breakdown of academic impact, for papers by Ajinath Kale Breakdown of academic impact, for papers by Ghada Abdel‐Fattah Breakdown of academic impact, for papers by Jianan Zou Breakdown of academic impact, for papers by Wataru Ohwada
Rankless by CCL
2026